Proven European health tech,
ready for your market.
We take European medical and intimate care brands into new markets.
A proven home market, taken abroad.
Who we are
Based near Berlin. We hold the international rights to the brands we commercialise and run every market outside the existing ones.
What you get
The brand, the regulatory dossier, the clinical documentation, artwork, assets in your language, samples. And a price we build with you rather than hand to you.
What we expect
Pharmacy or specialist retail access, regulatory competence for the local pathway, and the will to build a category rather than list a product and wait.
Deumavan: the first brand in the portfolio.
Lipid-based barrier protection for intimate skin care, formulated by Prof. Dr. Petersen. CE marked as a Class IIa medical device in the EU.
The Deumavan product portfolio
Markets
Where Deumavan is going next.
Six markets are live or launching. Thirteen are open. Germany, Austria and Switzerland are our home market, served by Kaymogyn, our DACH company.
Select an open market to start an enquiry.
Live or launching
Open for partners
DACH home market
How a partnership works.
Enquiry
Your market, your channel, your portfolio. One page is enough.
Fit check and NDA
Category overlap and regulatory route, then mutual confidentiality.
Business case together
Volumes, pricing, registration path, launch budget. No pre-set price list.
Launch
Registration, artwork, assets, campaign. We stay involved after the first order.
The most agile globalisation team you’ll meet.
Alain Cappelle
Managing Director
Mirko Wagner
Managing Director
Matthias Fuchs
Vice President Global Markets
and everything tech and AI
Moritz Schneider
Vice President Global Markets
and everything legal and regulatory
AI agents AI
Market research and partner briefings, around the clock